L-Carnitine Plays a Role in Preventing Cardiovascular Disease
A study published in the journal Renal Failure investigated the effects of L-carnitine on plasma coagulation and anticoagulation. The researchers enrolled thirty-six hemodialysis patients and the patients randomly received either 1000 mg a day L-carnitine or a placebo for 12 weeks. Blood was collected at the beginning of the trial and at the end to compare changes in plasma activity. The results were the L-carnitine group experienced significant reductions in serum C-reactive protein (marker for systemic inflammation) and plasma fibrinogen (an inflammation-related coagulator) in comparison to the placebo group. The authors stated “Therefore, l-carnitine may play an effective role in preventing cardiovascular diseases in these patients.”1
